About this episode

Dr. Jake New and Dr. Andrea Necchi discuss a significant clinical trial on intravesical recombinant BCG in muscle-invasive bladder cancer.

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Andrea Necchi discuss the ASCO 2026 Simultaneous Publication paper " Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single Arm Phase 2 Trial SAKK 06/19 ." LINK TO FULL TRANSCRIPT

More episodes of Journal of Clinical Oncology (JCO) Podcast

• Effectiveness of a Virtual Tobacco Treatment for Cancer Patients · July 16, 2026 · 24 min
• Phase 2 Study of Multi-Cancer Detection from Breath Samples · June 11, 2026 · 20 min
• JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma · June 1, 2026 · 10 min
• JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma · June 1, 2026 · 12 min
• JCO at ASCO 2026: Individual Patient Pooled Analysis of Low-Dose Tamoxifen in DCIS · May 31, 2026 · 11 min
• JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC · May 31, 2026 · 9 min

Explore listener stats, chart rankings, contacts and more on the Journal of Clinical Oncology (JCO) Podcast podcast page.